These Small Cap Cancer Drugmakers Have Big Growth Potential -- Seeking Alpha
In case some didn’t get the memo, the smaller drug makers have been on fire this summer.
On July 7, the Lucky 13 Buys list was unleashed. Since that time, SuperGen (SUPG) and Ariad Pharamaceuticals (ARIA) have each topped the list with gains of 45% and 85%, respectively. In recent sessions, both SUPG and ARIA have pulled back.
On Monday August 3, Lucky 13 Buys was a mere four weeks old. So far, the results have been impressive and far exceeding prior expectations. Five have advanced more than 30%. Nine are up over 20%, and 12 of the Lucky 13 Buys have increased by more than 13%.
www.ourbabytwins.blogspot.com
 | Company Earnings Earnings Dates, Surprises, Conference Calls |  | Financial Calendars Stock Splits, Economic, IPOs, Mergers |
 | Analyst Research Report Screener, Analyst Performance Center, Up/Downgrades, Sector/Industry Analysis |  | Research Tools Stock Screener, Historical Quotes, Real-Time Quotes |
 | Company Reports Annual Reports, SEC Filings, Financial Statements |  | Bonds Bond Center, Bond Screener, Bond News, Bond Rates |
 | Mutual Funds Mutual Fund Center, Fund Screener, Top Performers |  | Options Options Center, Options News, Options 101 |
Wednesday, August 5, 2009
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment